Publication from the Thomas J. Long School of Pharmacy at University of the Pacific.
Printing is not supported at the primary Gallery Thumbnail page. Please first navigate to a specific Image before printing.
-
Pacific RxTracts - December 2024
Pacific RxTracts
Articles
- Attruby: A Promising Treatment for Transthyretin Amyloid Cardiomyopathy
- Triple Threat: GMRx2, An Emerging Low-Dose Triple Pill For Hypertension
- New Treatment for Hemophilia A or B
- Breaking the Placebo Barrier: FDA Review Challenges Effectiveness of Popular Decongestant
- Exploring Bempedoic Acid: Potential Benefits for Statin-Intolerant Patients and Liver Health
- The Flu Vaccine: Meeting You Where You Are
- Unique Application of Statins for Radiotherapy-Induced Cardiotoxicity
- One Shot, Two Solutions: How Semaglutide Combats Obesity and Knee Osteoarthritis
-
Pacific RxTracts - November 2024
Pacific RxTracts
Articles:
- Semaglutide: Hope for Alzheimer's Prevention
- A New Potential Indication for Tirzepatide
- New Drug Target for Treating Schizophrenia
- The Prevent Calculator: Does America Have A Statin Problem?
- Weighing the Risks vs. Benefits of Liraglutide for Children
- CD19-CAR T-Cell Therapy: Revolutionizing Autoimmune Disease Treatment
- Conceived with Technology, Born with Risks: ART Babies and Heart Defects
- Machine Learning and Neural Networks: The Future of Clinical Pharmacy?. .
-
Pacific RxTracts - October 2024
Pacific RxTracts
Articles
- First Nasal Spray for Anaphylaxis Approved
- Statins: The Unexpected Therapeutic Benefits You Didn’t Know About
- Is COVID Driving Us Mad? The Mental Toll on the Unvaccinated vs. Vaccinated
- Acetaminophen’s Effects on Positive Empathy
- Semaglutide: More Than Meets The Eye
- RSV: Complications and New Therapies
- Contribution of Calcium Channel Blockers and Selective Serotonin Reuptake Inhibitors to the Risk of Fractures
